OnVagus is developing a novel, non-invasive therapeutic device to address cancer-associated cachexia, a debilitating condition marked by weight loss, muscle wasting, anorexia, and inflammation. By harnessing the gut-brain axis, OnVagus aims to improve patients’ quality of life, support treatment resilience, and help them continue the fight against cancer without pills, needles, or surgery.